Standout Papers
- Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (2022)
- Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial. (2022)
Immediate Impact
53 standout
Citing Papers
H3K18 Lactylation Potentiates Immune Escape of Non–Small Cell Lung Cancer
2024 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Bentong Yu being referenced
Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges
2021
TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bentong Yu | 526 | 390 | 230 | 445 | 56 | 1.2k | |
| Kota Ishizawa | 648 | 501 | 166 | 290 | 44 | 1.4k | |
| Yuko Kitagawa | 520 | 397 | 329 | 562 | 105 | 1.5k | |
| Hong Zhu | 314 | 354 | 157 | 235 | 60 | 1.2k | |
| Yi‐Ming Shyr | 618 | 383 | 146 | 582 | 65 | 1.5k | |
| Itzhak Avital | 344 | 480 | 444 | 449 | 42 | 1.5k | |
| Zhen Liu | 313 | 650 | 286 | 235 | 81 | 1.5k | |
| Wei Xu | 390 | 623 | 417 | 311 | 70 | 1.4k | |
| Yi‐Wei Xu | 204 | 451 | 209 | 329 | 95 | 1.2k | |
| Hye Won Lee | 309 | 477 | 257 | 163 | 52 | 1.2k | |
| Shunli Shen | 271 | 419 | 364 | 327 | 56 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...